Hirudin Plus Aspirin in the Secondary Prevention of Cardioembolic Stroke Due to Nonvalvular Atrial Fibrillation
Condition(s):Cardioembolic Stroke; Atrial FibrillationLast Updated:April 21, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Cardioembolic Stroke; Atrial FibrillationLast Updated:April 21, 2020Completed
Condition(s):r-Hirudin (Thrombexx) Efficacy in Treatment of HaematomasLast Updated:October 10, 2013Unknown status
Condition(s):Chronic Kidney Failure; Vascular Graft OcclusionLast Updated:October 5, 2007Completed
Condition(s):Lung CancerLast Updated:August 8, 2016Terminated
Condition(s):Eclampsia PreeclampsiaLast Updated:March 7, 2019Completed
Condition(s):Postherpetic NeuralgiaLast Updated:April 11, 2014Terminated
Condition(s):Coronary Heart DiseaseLast Updated:October 9, 2019Recruiting
Condition(s):Acute Coronary SyndromeLast Updated:December 30, 2020Recruiting
Condition(s):Acute Coronary Syndromes; STEMI; NSTEMILast Updated:January 29, 2015Unknown status
Condition(s):Acute Kidney InjuryLast Updated:January 30, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.